Synergism of CTLA4-IG and anti-CD4 monoclonal antibody treatment in a rat kidney transplant model.
Graser
E
E
Institute of Medical Immunology, Charité, Virchow-Hospital of the Humboldt-University Berlin, Germany.
Risch
K
K
Linsley
P S
PS
Hancock
W W
WW
Müller
A
A
Brock
J
J
Reinke
P
P
Kupiec-Weglinski
J W
JW
Volk
H D
HD
Lehmann
M
M
D000069594:Abatacept; D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D015703:Antigens, CD; D000943:Antigens, Differentiation / Q000032:analysis / Q000627:therapeutic use*; D015704:CD4 Antigens / Q000276:immunology*; D060908:CTLA-4 Antigen; D003404:Creatinine / Q000097:blood; D016207:Cytokines / Q000032:analysis; D004357:Drug Synergism; D006085:Graft Survival; D018796:Immunoconjugates; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology* / Q000473:pathology / Q000502:physiology; D051381:Rats; D011919:Rats, Inbred Strains; D011920:Rats, Inbred WF; D014184:Transplantation, Homologous
D000911:Antibodies, Monoclonal; D015703:Antigens, CD; D000943:Antigens, Differentiation; D015704:CD4 Antigens; D060908:CTLA-4 Antigen; C556708:Ctla4 protein, rat; D016207:Cytokines; D018796:Immunoconjugates; D007166:Immunosuppressive Agents; D000069594:Abatacept; D003404:Creatinine